92
Participants
Start Date
July 31, 2012
Primary Completion Date
March 31, 2014
Study Completion Date
September 30, 2014
Winclove-849
6 g of Winclove-849 containing Bifidobacterium bifidum W23, Bifidobacterium lactis W52, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19, Lactococcus lactis W58 at a concentration of 2.5 x 109 cfu/g
Placebo
A similar looking and tasting powder with no active substances
Department of Internal Medicine, Medical University of Geraz, Graz
Austrian Science Fund (FWF)
OTHER
Medical University of Graz
OTHER